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Abstract
Genome-wide association studies (GWAS) have become an effective tool to map genes and regions contributing to
multifactorial human diseases and traits. A comparably small number of variants identified by GWAS are known to have a
direct effect on protein structure whereas the majority of variants is thought to exert their moderate influences on the
phenotype through regulatory changes in mRNA expression. MicroRNAs (miRNAs) have been identified as powerful
posttranscriptional regulators of mRNAs. Binding to their target sites, which are mostly located within the 39-untranslated
region (39-UTR) of mRNA transcripts, they modulate mRNA expression and stability. Until today almost all human mRNA
transcripts are known to harbor at least one miRNA target site with an average of over 20 miRNA target sites per transcript.
Among 5,101 GWAS-identified sentinel single nucleotide polymorphisms (SNPs) that correspond to 18,884 SNPs in linkage
disequilibrium (LD) with the sentinels (r2§0:8) we identified a significant overrepresentation of SNPs that affect the 39-UTR
of genes (OR=2.33, 95% CI=2.12–2.57, Pv10{52). This effect was even stronger considering all SNPs in one LD bin a single
signal (OR=4.27, 95% CI=3.84–4.74, Pv10{114). Based on crosslinking immunoprecipitation data we identified four
mechanisms affecting miRNA regulation by 39-UTR mutations: (i) deletion or (ii) creation of miRNA recognition elements
within validated RNA-induced silencing complex binding sites, (iii) alteration of 39-UTR splicing leading to a loss of binding
sites, and (iv) change of binding affinity due to modifications of 39-UTR folding. We annotated 53 SNPs of a total of 288 trait-
associated 39-UTR SNPs as mediating at least one of these mechanisms. Using a qualitative systems biology approach, we
demonstrate how our findings can be used to support biological interpretation of GWAS results as well as to provide new
experimentally testable hypotheses.
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Introduction
The state of knowledge regarding development, progression
and inheritability of human diseases has long since outrun the
classical understanding. There are only few disorders where
monogenic causes could be determined. Also, the genetic links
to disease incident are missing to a substantial part and the
complexity of pathways encompassing pathogenic effects can still
not be limited upwards. In recent years, more and more
evidence is emerging that microRNAs (miRNAs), a class of
small non-coding RNAs, play an important role in human
traits. Databases collecting information on miRNAs mediating
human disease such as miR2Disease [1] or PhenomiR [2] list
several hundred miRNAs with proven roles in way above 100
human diseases.
MiRNAs are key posttranscriptional regulators of most known
cellular processes and have been associated with cell fate decision,
development, and stress response. Additionally, miRNAs have
been identified to be usable as biomarkers for human diseases [2–
5]. With growing knowledge on their targets, which are believed to
make up more than 60% of all protein-coding genes [7], new
regulatory and disease-mediating gene networks were discovered
[8–11]. Because of the ability of single miRNAs to regulate not
only one but up to several hundred genes, they depict a promising
drug target for disease pathways involving multiple genes. With
the recent advances of the crosslinking immunoprecipitation
(CLIP) technology, it has become feasible to experimentally
determine miRNA-target interactions and the exact binding sites
of the RNA-binding proteins (RBPs) on transcriptome scale [12–
15].
As soon as the importance of miRNA functioning for human
health was realized, approaches were undertaken with the
objective to identify potential interrelations of miRNA dysregula-
tion and genetic variation. However, until now neither the data on
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miRNA targeting information provided a sufficient basis for such
analyses. For instance, mutations in the 39-UTR, the major target
of miRNA-mediated regulation, have long been (and are still)
neglected for the most part in association studies. Therefore, only
few particular cases of polymorphisms affecting miRNA regulation
pathways have been identified, yet [16,17]. Up to now such studies
are often limited to effects on (mostly predicted) miRNA target
sites [17,18]. However, the 39-UTR harbors several other
functional elements which may, if affected, also mediate disruption
of miRNA regulation pathways. It has been assumed, for instance,
that the loss of a polyadenylation (poly(A)) signal can cause genetic
diseases by non-specific degradation of the mRNA [19]. Recent
experiments suggest that this effect may be based on a functional
correlation of poly(A) signal efficiency and miRNA-mediated
repression [20]. Further, the structural accessibility of an RNA
region is an important feature for the binding affinity of RNA-
induced silencing complex (RISC) target sites [21]. It has been
shown that mutations in RNAs have large local as well as global
structural effects [22] and that altered target accessibility can
reduce miRNA-mediated posttranscriptional repression to a scale
comparable to that of mutations disrupting miRNA recognition
element (MRE) sequence complementarity [23]. Finally, polymor-
phisms affecting splice sites can lead to radical sequence changes
increasing susceptibility to diseases, an effect which is suspected to
be partly due to altered translation efficiency of the affected
mRNA [24] - which is characteristic for miRNA functioning.
The success of genome-wide association studies (GWAS) in
determining the genetic causes of some common diseases led to an
immense increase of the efforts put on screening common alleles
for disease involvement. Since then, more and more loci associated
with trait susceptibility are detected. GWAS can, however, neither
identify causal genes in associated loci nor provide functional
mechanisms behind observed association signals. Consequently,
many identified GWAS signals are awaiting mechanistic charac-
terization and the rate at which GWAS signals are currently
discovered necessitates systematic and scalable functional ap-
proaches [25].
When it became clear that only few diseases are due to
common risk alleles, sequencing endeavors have been performed
to identify putatively rare variants hiding behind the signals
detected in GWAS. In some cases these approaches successfully
identified rare causative variants predisposing to disease.
However, the expected breakthrough failed to appear as in
several cases sequencing of risk loci did not provide further
knowledge [26–28]. With the situation additionally compounded
by the fact that most GWAS-identified alleles are located within
non-coding regions, now one focus is laid on the identification
of regulatory variants. In this work, we concentrate on the
influence of GWAS-identified variants on miRNA-mediated cis-
acting regulatory effects.
We assess the potential impact of trait-associated SNPs on
miRNA regulation pathways using publicly available GWAS data
[29,30]. We describe potential posttranscriptional effects of SNPs
by systematically investigating mutations within the 39-UTR of
human transcripts for interference with poly(A) signals, 39-UTR
splicing, 39-UTR secondary structure changes and MREs. Using
the example of rs10923 in the 39-UTR of SMC4 we show how our
findings can be utilized in the biological interpretation of GWAS
results in a systems biological manner.
Results
Trait-associated Variants are Significantly
Overrepresented in the 39-UTR
We compared the amount of trait-associated variants within the
predefined five function classes of SNPs (intergenic, intronic, 59-
untranslated region (59-UTR), coding sequence (CDS), and 39-
UTR) to examine a potential location bias of these markers. Of
18,884 SNPs contained in the extended GWAS-SNP set (GWAS-
SNPs and their highly correlating LD partners, r2§0:8), we found
436 to be located in the 39-UTR of 326 human genes
(OR=2.331, Pv10{52, referred to as 39-UTR SNPs). This is a
higher enrichment than for sentinel SNPs only (OR=2.059,
Pv10{10). We calculated the probability to get an 39-UTR
enrichment this strong in a random subset of HapMap-SNPs [31–
33] of comparable size which confirmed significance
(Pv1:1:10{7). For further validation of this enrichment we
looked at the dependencies between the OR and the minor allele
frequency (MAF) as well as different r
2 thresholds.
When we adjusted for r
2 in the extension of the GWAS-SNPs,
we found that the distribution of ORs locally stabilizes around a
threshold of r2~0:8 (Figure 1A). This limit thus seems to fit the
data better than more rigid thresholds and was therefore chosen in
this work. To rule out a false increase of the enrichment due to
correlating SNPs in the same 39-UTRs (SNP-gene ratio *1.34) we
binned the complete HapMap-SNPs into blocks with an all-vs.-all
r2§0:8. More than one million HapMap SNPs were binned
together in about 371,000 blocks containing more than two SNPs.
The remaining SNPs only showed pairwise or no LD at the chosen
threshold. When we included all SNPs after binning, the OR for
39-UTR enrichment was even greater than without binning
(OR=4.27, 95% CI=3.84–4.74, pv10{114). Considering only
the SNPs within the *371,000 blocks the enrichment still holds
significance (OR=1.828, 95% CI=1.63–2.04, pv10{24). As
about 10% of the 39-UTR SNPs are not contained in theses
blocks, we suggest that this value presents an underestimation of
the actual enrichment. The reason for the stronger enrichment
after binning is that the SNP count within the LD blocks depends
on the location of the SNPs. While intronic and intergenic SNPs
are reduced to less than 35% (block-SNP ratio) by binning, SNPs
in exonic regions present less extensive LD patterns (reduction
only to about 81%).
By analyzing the MAF, we found the extended GWAS-SNPs to
hold a commonly higher MAF than the HapMap-SNPs, regardless
of their chromosomal location. However, the comparison of the
MAF distribution of the 39-UTR SNPs to the MAF distribution of
other extended GWAS-SNPs revealed a slight trend of 39-UTR
SNPs towards moderate MAF frequencies between 0.1 and 0.4.
This trend becomes more explicit when comparing the 39-UTR
SNPs to the combined extended GWAS-SNPs in the other two
exonic regions (i.e. 59-UTR and CDS). In comparison, 39-UTR
SNPs show underrepresentation of the intervals 0.0–0.1
(OR=0.88), 0.2–0.3 (OR=0.70) and 0.4–0.5 (OR=0.78) whereas
the other two intervals are significantly (Pv0:05) overrepresented
(OR0.1–0.2=1.40 and OR0.1–0.2=1.59). To investigate if 39-UTR
SNP enrichment values hold only for specific MAFs, we
recalculated the ORs against the HapMap-SNP set in dependency
of the MAF. The ORs resulting for the five MAF intervals follow
roughly the pattern of over2/underrepresentation observed in the
comparison with the other extended GWAS-SNPs but never lose
significance or fall below an OR of 2.0 (Figure 1B).
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Figure 1. Statistical analysis of 39-UTR enrichment values and determination of the folding correlation coefficient threshold. A: SNP
enrichment in the 39-UTR in dependency of different LD thresholds. Displayed are the ORs and confidence intervals for five cut-offs. Accumulative 39-
UTR SNP sets were calculated. The fitted distribution (dashed line) points out the stabilization of the OR around a threshold of 0.8. B: SNP enrichment
in the 39-UTR in dependency of the minor allele frequency. Displayed are the ORs and confidence intervals for the 5 different MAF bins. SNP
counts were compared within the respective bins. C: Probability distribution of correlation coefficients (p) between wild-type and mutated structures
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Metabolism
To investigate whether the 326 genes affected by 39-UTR
mutations share common characteristics, we performed gene
enrichment analyses with respect to disease involvement and
functional annotations.
By mapping the traits associated with 39-UTR variants to
MeSH terms we retrieved a total of 49 observed disease classes.
The most abundant categories were immune system diseases,
mental disorders, digestive system diseases, nervous system
diseases, and neoplasms. The distribution of the 39-UTR SNPs
within these disease classes showed no significant overrepresenta-
tion compared to the count of studies performed for the single
disorders in the GWAS Catalog. When comparing the number of
39-UTR SNPs per disease to the count of all non-39-UTR
extended GWAS-SNPs, we found only lipid concentrations to be
significantly (Pv1:3:10{3) enriched in the 39-UTR set.
Gene set enrichment analysis (GSEA) revealed only four
significantly enriched (Pv0:05 after Bonferroni correction)
functional annotations in this set: lipid metabolism, axon growth,
activation of the immune response/inflammation (9 terms), and
regulation of/response to cell signaling (10 terms). Using DAVID
[34,35], we also checked for overrepresentation of disease terms
not limited to the GWAS Catalog and found three enriched terms
(Pv0:05 after correction): Dyslipidemia (background set: Online
Mendelian Inheritance in Man database), neurological diseases,
and infections (background set: Genetic Association Database
[36]).
Evidence for Impact on miRNA-mediated Regulation
The efficacy of a miRNA to control target mRNA translation
relies, among others, on three sequence-based features: correct
mRNA processing, presence of a functional MRE, and accessibil-
ity of the RISC binding site. To find out to which extent trait-
associated SNPs in 39-UTRs affect miRNA functioning, we
examined four mechanisms potentially compromising these
features (Figure 2, Table 1. This analysis was limited to
transcripts featuring both 39-UTR SNPs and validated RISC
binding sites. The according data set contained 288 SNPs on 409
transcripts and 219 genes, respectively. Firstly, we investigated
potential effects of SNPs on mRNA processing by interfering with
poly(A) signals. We found four SNPs affecting hexamers with a
sequence characteristic for poly(A) signals, however, none of these
hexamers was located near a validated poly(A) site. A functional
effect of those variants on mRNA processing thus seems unlikely.
Secondly, we analyzed the impact on mRNA splicing. We
identified seven SNPs (*2:4%) predicted to interfere with RNA
splice sites (Figure 2D, Table S1). Six of those are predicted to
create new acceptor sites and one to create a new donor site
(Figure 2D). SNPs interfering with splice sites located at an
exon/intron or intron/exon border as annotated in RefSeq were
not found. The probability to observe such an effect by chance is
P~1:78:10{2 for acceptor sites and P~1:41:10{2 for donor
sites. In all seven cases, the predicted gain of splice sites results in
exon shortening, leading to a noticeable loss (46% on average) of
RISC binding sites in the accordant transcripts. Thirdly, we
searched for SNPs which may affect the secondary structure of the
39-UTR proximal to a validated RISC binding site causing an
altered accessibility of the region. This resulted in 14 SNPs
(*4:9%) predicted to affect the binding affinity of the RISC
through changed secondary structure of the 39-UTR (Figure 2B,
Table S2). Fourthly, we examined direct effects of SNPs on
MREs located in validated RISC binding sites. We found 22 SNPs
(*7:6%) disrupting MREs (Figure 2C, Table S3), and 28 SNPs
(*9:7%) creating new MREs (Figure 2C, Table S4). The
overlap between the SNP sets creating and disrupting MREs, i.e.
SNPs substituting the MRE of one miRNA by a MRE of another
miRNA, amounts to 13 variants. Accordingly, a total of 37 unique
SNPs (*12:8%) directly affect MREs. The probability of
obtaining these amounts of SNPs affecting MREs randomly was
P~1:27:10{2 (disruption) and P~8:76:10{4 (creation). Addi-
tionally, we found that only 11% of SNPs enhancing (i.e.
extending an already existing seed match) or creating a MRE
were conserved across mammals which was a lower fraction than
for SNPs causing one of the other effects (folding=29%,
splicing=29%, MRE disruption=27%).
SMC4 – from Primary Biliary Cirrhosis to Cancer
The autoimmune disease primary biliary cirrhosis (PBC) is
associated with the damaging of the small bile ducts and is
mediated by auto-antibodies [37–39]. The autoimmune response
caused by those antibodies leads to inflammation followed by
aggregation of dead cells. Apoptosis is induced, among other
things, by reactive molecules effecting DNA damage [40,41]
leading to a build-up of scar tissue (i.e. cirrhosis). The genetic
background of the disease was focus of a recent GWAS [42],
however, the rationale of the study was restricted to the major
histocompatibility complex and interleukins. Causative variants
could not be identified so far. One of the SNPs (rs4679904)
reported in the study is in high LD (r2~0:86) with the 39-UTR
SNP rs10923 in SMC4 which is part of the Condensin I complex
[43]. Interestingly, DNA repair genes such as PARP1 and XRCC1
are over-expressed in cirrhotic tissue and are in this context
hypothesized to feature pathogenic effects [44]. For full function-
ing of the PARP1-XRCC1 complex in single-strand break repair, an
association with the Condensin I complex is established [45].
The SNP rs10923 is localized within an experimentally
validated RISC binding site [14] and lies directly in the seed
complementary region of hsa-mir-299-5p, a miRNA that has been
shown to be up-regulated in PBC patients [46]. The minor G
allele of rs10923 disrupts the 6merc seed complementary region
(Table 1) and thus the ability of the miRNA to bind the transcript
(Figure 3) [47]. Although we also observe the gain of a new MRE
when introducing the minor allele of the SNP (Table 1),
expression data from the MuTHER study [48] supports the
hypothesis of deactivated miRNA-control as it shows significant
(Pcombinedv5:9:10{4) association of the G allele with increased
SMC4 expression in lymphoblastoid cell lines. We suggest that, by
this process, rs10923 contributes to the phenomenon of DNA
repair perturbation in cirrhosis (Figure 4) [44]. Beyond that this
may indicate a rate-limiting character of SMC4 in the generation
of the Condensin I-PARP1-XRCC1 complex. Furthermore, PBC
patients present elevated risk to develop different types of cancer
[49,50] representing a potential explanation for the deranged
DNA repair functionality in the disease. In cancer development
and progression, up-regulated DNA damage response is associated
with mutagenesis and resistance to radio- and chemotherapy
[41,51–53].
of RBP-binding regions. Below a cut-off for the correlation coefficient of 0.55 (displayed in gray) the probability to observe a change of RNA secondary
structure of this scale by chance amounts to less than 5%.
doi:10.1371/journal.pone.0036694.g001
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Although thousands of SNP-trait associations have been
published and the applicability of GWAS is broadly appreciated,
the associations identified by GWAS hold predictive power for
only a small fraction of disease incidence so far [25,54]. Finding
the causative variants predisposing individual disease risk therefore
presents the main dilemma of GWAS. As long as comprehensive
sequencing data is missing for most associated loci, frameworks are
needed providing a first characterization of potential disease-
mediating mechanisms.
Here, we suggest that associated common or unknown rare
variants in the 39-UTR depict posttranscriptionally regulatory
variants which, to differing extent, affect disease development and
progression by interfering with miRNA regulatory networks. The
differing impact of 39-UTR SNPs can be explained with two facts:
first, human mRNAs are mostly targeted by multiple miRNAs at
different target sites which may allow for compensating the loss of
a single binding site; and second, the extent to which mRNAs are
silenced by miRNAs depends on multiple factors such as tissue-
specific miRNA expression, the binding affinity of the RISC and
the degradation rate of the mRNA [55,56]. Thus, unlike
mutationally driven alterations of the amino acid sequence of a
protein or disruption of a transcription factor binding site in
promoter or enhancer regions, interferences with miRNA
regulation may show tissue-specific effects sizing from low or not
distinguishable to high or even causative.
Based on recently available data, our results clearly show that
several lines of evidence become obvious that miRNAs play an
important role in genetically determined posttranscriptional
disease development and progression. There is no evidence for
considerable direct interference of miRNA processing: only one
SNP (rs2168518) was found to be located in the hairpin of hsa-mir-
4513. But we observed a significant overrepresentation of trait-
associated SNPs in the 39-UTR that strongly suggests a functional
coherence between genetic variants and miRNA regulation
pathways on the cis-regulatory level.
Several studies assessing the disease-mediating power of
miRNAs confirmed their involvement in the mediation of diverse
traits [3,57,58] suggesting that traits associated with 39-UTR SNPs
belong to heterogeneous disease classes. We observed a similar
trend as our results showed a correlation between the number of
traits belonging to the distinct disease classes and the number of
published studies on the corresponding traits in the GWAS catalog
[30]. This indicates that with an increasing number of studies on
other traits the count of disease classes associated with 39-UTR
SNPs will increase, too. Moreover, an uniform number of studies
on the traits should lead to an equal distribution of the represented
disease classes. Of a total of 49 disease classes assigned to the 39-
UTR SNPs, only lipid concentrations showed a significant
enrichment within the phenotypes investigated by GWAS.
The functional enrichment analysis revealed that genes having a
39-UTR SNP are involved in a wide range of cellular processes.
The most intriguing finding is the replication of the enrichment of
lipid traits by GSEA which, additionally, detected an enrichment
of the lipid metabolism on the level of gene function. The
enrichment of terms regarding the regulation of the immune
response and of inflammatory processes, on the contrary, reflects
the phenotype bias of GWAS towards autoimmune and inflam-
matory diseases [59]. The other overrepresented terms are
connected to multiple downstream effects indicating a major
participation of the genes in the initiation and regulation of cellular
pathways.
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Figure 2. Mechanisms mediated by 39-UTR SNPs affecting miRNA targeting. A: Regular binding of the RISC to the target mRNA. B: Binding
of the RISC and, thus, miRNA-mediated silencing is inhibited by a change in RNA secondary structure. C: A mutation within the MRE seed site disrupts
the ability of a certain miRNA to target a transcript. Here, the opposite effect also applies, i.e. a new MRE seed site is formed by a polymorphism which
enables targeting by a miRNA usually not controlling the respective transcript. D: Altered splicing by acceptor or donor splice site gain. The existing
splice variants (I and II, grayed) are extended by mutationally introduced additional splice variants: (III) A present acceptor site (A1) is substituted by a
new acceptor site (Amut), and (IV) a naturally occurring donor site (D2) is replaced by a new donor site (Dmut). Both effects may lead to a considerable
loss of exon sequence (displayed in red) and, thus, RISC binding sites. E: The percentages of classified SNPs mediating the single mechanisms. The
greatest amount of functionally annotated 39-UTR SNPs directly affect MRE sequences, followed by SNPs changing the RNA secondary structure and
SNPs with an predicted effect on 39-UTR splicing.
doi:10.1371/journal.pone.0036694.g002
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SNP Gene Effects Traits
rs1121 PDXDC1 MRE creation Height
rs4564 DLD MRE disruption Ulcerative Colitis
rs6706 TRIP6 MRE disruption Resting Heart Rate
rs7089 TMUB2 MRE disruption; MRE creation Bone Density
rs7097 POLR1D MRE creation Large B-Cell Lymphoma
rs7118 ZFP90 MRE disruption; MRE creation Ulcerative Colitis
rs7119 HMG20A MRE disruption Type 2 Diabetes
rs7371 GNAI3 Acceptor gain Major Depressive Disorder
rs7444 UBE2L3 Folding Crohn’s Disease; Systemic Lupus Erythematosus
rs8523 ELOVL2 MRE disruption; MRE creation Phospholipid levels
rs9253 MEAF6 MRE disruption Hematological Phenotypes
rs9927 PYGB MRE creation Liver Enzyme Levels
rs10923 SMC4 MRE disruption; MRE creation PBC
rs11700 E2F4 MRE creation Coronary Heart Disease
rs12439 CLIC4 MRE disruption; MRE creation Height
rs12916 HMGCR MRE creation Cholesterol levels; Metabolic Traits
rs12956 RYBP Folding Height
rs13099 TMED10 Folding Height
rs42038 CDK6 Folding; Acceptor gain Height
rs42039 CDK6 MRE creation Rheumatoid Arthritis
rs232775 MYSM1 MRE creation Diabetic Retinopathy
rs699779 NOTCH2 Acceptor gain; MRE disruption Type 2 Diabetes
rs823136 RAB7L1 MRE creation Parkinson’s Disease
rs835575 NOTCH2 Folding; MRE disruption; MRE creation Type 2 Diabetes
rs835576 NOTCH2 MRE disruption; MRE creation Type 2 Diabetes
rs1045100 ATG16L1 MRE disruption; MRE creation Crohn’s Disease
rs1045407 ZNF678 Folding; MRE creation Height
rs1046917 FN3KRP Folding Glycated Hemoglobin Levels
rs1047440 CEP120 MRE disruption; MRE creation Body Mass Index
rs1058588 VAMP8 MRE disruption Prostate Cancer
rs1379659 SLIT2 MRE disruption Echocardiographic Traits
rs2032933 RMI2 MRE creation Celiac Disease
rs2071518 NOV MRE creation Blood Pressure
rs2077579 DDX6 Folding PBC
rs2229302 HOXB2 MRE disruption; MRE creation Primary Tooth Development
rs2244967 VSTM4 Acceptor gain Serum Uric Acid
rs2282301 RIT1 Folding Conduct Disorder
rs2293578 SLC39A13 MRE creation Body Mass Index
rs2564921 RFT1 Folding Height
rs3816661 CD276 MRE disruption Liver Enzyme Levels
rs3821301 TANC1 Folding Sudden Cardiac Arrest
rs4770433 SACS MRE disruption Protein Quantitative Trait Loci
rs4819388 ICOSLG Folding; MRE creation Celiac Disease
rs4973768 SLC4A7 Donor gain Breast Cancer
rs6722332 WDR12 Acceptor gain Coronary Heart Disease; Myocardial Infarction
rs7350928 KIAA1267 MRE disruption; MRE creation Parkinson’s Disease
rs7528419 CELSR2 Acceptor gain Cholesterol levels; Metabolic traits; Cardiovascular Disease; Myocardial Infarction;
Response to Statins
rs8176751 ABO MRE creation Hematological Phenotypes
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polymorphisms and poly(A) signals, our extensive analysis of the
potential impact of GWAS-identified SNPs on functional elements
in the 39-UTR revealed several mechanisms whereby variants may
affect miRNA-mediated regulation. The smallest fraction of
potentially functional 39-UTR SNPs affects 39-UTR splicing.
These SNPs are predicted to mediate miRNA target site loss,
mostly through the gain of acceptor splice sites (donor splice site
gain only occurred once) resulting in shortened 39-UTRs. That
altered splicing is the rarest found mechanism can be explained by
the huge impact it mediates on miRNA targeting which manifests
in the high fraction of target site loss (46% on average) for the
affected transcripts. The second mechanism is the SNP-mediated
alteration of RNA secondary structure of a RISC binding region.
The impact of RNA folding on the binding affinity of RBPs has
already been described [21,23]. However, the extent to which this
phenomenon translates into miRNAs mediating human disease
development is unknown. With our results we provide a first data
basis on potentially pathogenic RNA structural changes which
may serve as a starting point to investigate this matter further. The
third and most abundant mechanism we could identify is the direct
alteration of MRE sequences. We find not only that GWAS-
identified markers in the 39-UTR show a significant enrichment
within MREs, but also identify a novel scenario of how miRNA
dysregulation may take effect: the substitution of the recognition
element of one miRNA by one of another miRNA. While a
disruption (or creation, respectively) of a MRE enables a rather
straightforward rationale, that is the tissue-specific repression (or
enhancement, respectively) of miRNA regulation, this scenario
makes interpretation rather complex. Such a substitution may
imply concurrent but simultaneously diverging effects in different
tissues, depending on the respective expression patterns of the two
miRNAs, possibly leading to systemic disturbances of several cell
types. The overlap between the two sets of SNPs which disrupt and
create MREs amounts to 13 polymorphisms and constitutes more
than one third of the set of variants affecting MREs - which is a
surprisingly high number. We believe that the transcripts affected
by a SNP mediating this effect may present quite interesting
targets for further studies. Moreover, this highest fraction (39%) of
effective 39-UTR SNPs shows a low conservation indicating that
the creation of a MRE may be an abundant process of functional
SNPs.
In general, our findings indicate that miRNAs play an
important role in genetic variants causing trait development.
Therefore, novel aspects not only for the interrelations in
pathogenic disturbance of cellular processes, but also for the
coherence of different traits can be addressed. For instance,
differential tissue-specific expression patterns of miRNAs in
combination with genetic variants may shed light on the still
unknown functions driving the same cellular pathways to feature
different effects in diseased and healthy individuals. Thus, closing
the gap between trait-associated mutations and impaired miRNA-
Table 1. Cont.
SNP Gene Effects Traits
rs10892082 PAFAH1B2 Folding Protein QTLs; Triglyceride Levels
rs11067231 MMAB MRE creation Cholesterol levels
rs11542478 FAM110C Folding Information Processing Speed
rs11713355 SLC6A6 MRE disruption; MRE creation Cognitive Performance
rs17574361 KIAA1267 MRE disruption; MRE creation Parkinson’s Disease
The first column gives the rs-number of the SNPs, in the second column the HGNC symbol of the affected genes are listed and the third column describes the functional
mechanisms which could be assigned to the SNPs. The last column contains all traits associated with the respective SNP.
doi:10.1371/journal.pone.0036694.t001
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Figure 3. Impact of the SNP rs10923 on miRNA-mediated
repression of SMC4. Shown is the mRNA:miRNA duplex for the
reference allele of rs10923 (lower part). The minor allele of the SNP
(position adumbrated by the light red box) disrupts the seed
complementary region. In the upper part of the figure, the expression
pattern of SMC4 in lymphoblastoid cells is illustrated. The minor G allele
of the polymorphism is significantly (Pcombinedv5:9:10{4) linked to an
increased abundance of SMC4 transcript. For the illustration of
expression values Genevar output was adapted [89].
doi:10.1371/journal.pone.0036694.g003
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ing of the interconnection of those functional entities.
We found 326 candidate genes, and on the example of SMC4
we show that the incorporation of miRNA related information can
be used to construct models of potential disease-driving mecha-
nisms in a systems biological fashion. In this case, we present a
very simple one-gene/one-miRNA scenario. However, up to now
SMC4 and PBC have never been connected, as well as an
association of PBC and cancer only exists in clinical ratios. But our
suggestion of a highly active, SMC4-dependent DNA repair
machinery is not only a likely cellular response mechanism to
apoptosis signals in cirrhotic tissue. It also provides the link to cell
transformation and cancerogenesis. Therefore, in the context of
miRNA biology plausible coherences can be established for
common variants with unknown effect. This also points out that,
beyond statistical evaluations, case-specific detailed analyses may
greatly outrange global approaches in the biological interpretation
of GWAS results.
Our findings highlight numerous starting points for biomedical
research. To advance the potential of conclusion drawing in
GWAS results interpretation, it may be invaluable to overcome
the GWAS bias towards the coding sequence and extend
approaches based on 39-UTR mutations. Conversely, more
comprehensive data on miRNA binding sites might enhance our
understanding of miRNA regulation functioning. It may also be of
interest to investigate the most suspicious cases described in this
work further. Moreover, determination of miRNA regulation via
RISC binding to other mRNA locations than the 39-UTR might
shed light on the effect of coding-synonymous trait-associated
alleles. The combination, i.e. extensive measurements of miRNA-
mediated gene regulation in patients with traits for which a
plausible model of miRNA involvement can be created in the
context of associated mutations in the 39-UTR, may further
provide new perspectives of disease progression.
But the implications of our findings go beyond GWAS and
miRNAs. Considering the advances made in the exploration of
the still poorly understood elements of the genome, the impact
of the presented results are pointed out. Just recently, the
approaches of the modENCODE project [60,61] led to the
validation of the hypothesized hierarchical structure of physical
regulatory networks in eukaryotes which are based on a
sophisticated interplay of miRNAs and transcription factors.
Thus, the important role of this class of non-coding RNAs in
the regulatory machinery of the cell is brought out on a large-
scale level. If those findings can be transferred from the studied
model organisms to human, the analysis of impairment of the
transcription factor-miRNA network balance by mutationally
altered target site functioning may lead to a completely new
definition of genetically predisposed diseases on a RNA-
mediated, regulatory basis. Also, miRNAs are only one class
of non-coding RNAs which have been proven to feature
regulatory power. Interference by e.g. piwi-associated RNAs,
small interfering RNAs or large intergenic RNAs which all are
incorporated in protein-containing complexes targeting specific
genes (especially, their 39-UTR) will have to be assessed in this
context to gather further insights.
Figure 4. Impact model of mutated SMC4 in primary biliary cirrhosis. Inflammation follows the autoimmune response leading to the
activation of the MAPK-pathway via signal molecules as e.g. TNF-alpha. Transcription factors activated as downstream effect of MAPK activation lead
to over-expression of DNA repair genes. The in PBC over-expressed hsa-mir-299-5p is hypothesized to target SMC4 at the seed complementary region
where rs10923 is located. With the major allele, SMC4 is silenced, whereas the mutated SMC4-G cannot be bound by hsa-mir-299-5p and therefore is
translated without interference. This results in the more frequent association of the Condensin I-PARP1-XRCC1 complex contributing to disturbed DNA
repair in cirrhosis tissue.
doi:10.1371/journal.pone.0036694.g004
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Acquisition of the SNP Data Sets
We downloaded the Catalog of Published Genome-Wide
Association Studies [29], which includes information about
5,101 unique SNP-trait associations with a p-value of
Pƒ1:0:10{5 [30]. We refer to this set as GWAS-SNPs. The
GWAS-SNPs were extended by highly correlating SNPs with
strong LD (r2§0:8) in the HapMap3 CEU panel (Utah residents
with northern and western European ancestry from the CEPH
collection) [31–33]. This set, further referred to as extended
GWAS-SNPs, contains 18,884 variants retrieved by using SNAP
[62].
As background distribution for localization enrichment we used
the 2.7 million SNPs from the CEU panel of the joint HapMap
Phases I, II and III (release 27, referred to as HapMap-SNPs) for
which genotype information was available [31–33]. All SNPs were
mapped to official identifiers [63] using SNAP [62] and their
genome build NCBI36/hg18 coordinates were retrieved from the
UCSC (University of California Santa Cruz) Table Browser [64].
For a background set representative for the HapMap-SNPs with
comparable properties as the extended GWAS-SNPs, we ran-
domly selected 5,101 SNPs from the HapMap-SNP set and
extended this set, analogous as for the GWAS-SNPs, with SNPs in
strong LD using r2§0:8. This process was repeated 1000 times.
For statistical evaluation of the localization enrichment and the
effects on functional elements against this background, we
computed the respective statistics for all 1000 sets, fitted a
distribution to the resulting values and retrieved the probability to
observe the statistic obtained for the extended GWAS-SNPs. As
the HapMap-SNPs are a superset of all other SNP sets, i.e. the
1000 random sets and the GWAS-SNPs as well as the extended
GWAS-SNPs, we always performed SNP-based annotations for
the whole HapMap-SNP set. Thus, we simultaneously retrieved
the properties of all other SNP sets.
We mapped all SNPs on genomic locations of protein-coding
genes and miRNA genes. The genome annotations were obtained
from the UCSC Table Browser [64] based on the NCBI
Reference Sequence annotation (genome build NCBI36/hg18)
[65] and from miRBase release 18 (genome assembly GRCh37/
hg19) [66–68]. We used the UCSC liftOver tool [69] to convert
the genomic miRNA hairpin coordinates to the NCBI36/hg18
assembly. The chromosomal function of the SNPs was categorized
into five classes: intergenic, intronic, 59-UTR, CDS, and 39-UTR.
To assess differences regarding the MAF in and between the SNP
sets we computed the distribution in bins of ten percent range for
all SNPs. MAF data was used as given for the HapMap-SNPs.
Adjustment for r
2 values in the localization enrichment analysis
was performed accumulatively in 5% steps. For binning of
HapMap-SNPs into LD blocks, we searched for all SNP sets with
an all-vs.-all r2§0:8. Each SNP was uniquely assigned to a LD
block. The localization of the blocks was defined as the subset of
the five classes occurring in the annotation of the SNPs contained
in the respective bin.
We used the algorithm PhastCons from the PHAST package
[70] to calculate the maximum likelihood of a SNP to be
conserved across 17 vertebrates. We required a score greater than
0.57 to classify a site as conserved in mammals [71].
Annotation of RISC-target Regulatory Relationships
To analyze the single nucleotide mutation effect on miRNA
targeting, we used the high-throughput transcriptome-wide CLIP-
Seq interaction maps describing sites of the RBPs Argonaute and
TNRC6 in human HEK293 cells [14] as provided by the starBase
database [72]. The available chromosomal coordinates of the
CLIP-Seq clusters were converted to the NCBI36/hg18 genome
build and mapped to protein-coding genes according to the NCBI
Reference Sequence annotation [65]. The final set contained
139,254 locations of RBP binding regions on 24,442 transcripts.
48% of sites were located within a 39-UTR.
Examination of Polyadenylation Signals
We obtained chromosomal positions of poly(A) signals from the
PolyA DB for mRNA polyadenylation sites [73,74]. As the
position of poly(A) sites is described to be located 10–30
nucleotides (nt) downstream of the poly(A) signals [73,75], SNPs
within this range site were determined. We then extracted 11 nt
long mRNA sequences centered around these 39-UTR SNPs and
examined the sequences for the most abundant poly(A) signal
variations according to [75]. We classified a SNP as effecting a
poly(A) signal if either creation of a new poly(A) signal sequence or
disruption of an existing signal occurs. Classification of a SNP as
not effecting a poly(A) signal was carried out if there was no
existing signal in the 11 nt sequence for both the wild-type allele
and the mutated allele or if the respective allele does not only
disrupt a signal but simultaneously creates another poly(A) signal
(‘‘synonymous mutation’’).
Determination of Splice Sites
WeappliedtheNNSplicealgorithmfromtheBerkeleyDrosophila
Genome project [76] to identify changes in splice sites. As input we
usedagenomicDNAsequencewindowof60 ntcenteredattheSNP
position of the wild-type and the mutated type. Predicted splice sites
withalikelihoodgreaterthan0.5wereretainedneglectingcaseswith
marginalchanges[77].Alltypesofsplicesitechangewereconsidered:
loss/gain of splice site and increase/decrease of likelihood. The
distanceofanysplicesitechangetoanexonjunctionsiteasdefinedby
the NCBI Reference gene annotation (genome build NCBI36) [65]
was computed. We filtered lost acceptor sites or sites exhibiting an
increase/decrease in their likelihood if they were located between
100 nt upstream and 10 nt downstream of a reference intron/exon
border. Lost donor sites or sites with an increased/decreased
likelihood were retained if they were located between 10 nt up- and
downstream of a reference exon/intron border. A gain of a
completely new splice site was always kept[77].
Analysis of RNA Structural Properties
To account for structural changes caused by SNPs we used the
RNAfold algorithm from the Vienna RNA Package version 1.8.5
[78]. We considered the ensemble of possible RNA conformations
by calculation of the partition function and the base pairing
probability matrix of the wild-type and the mutated 39-UTR
sequences [79]. The row sums were computed to define a pairing
score for each nucleotide. We extracted a 41 nt long score vector
centered at an RBP:RNA interaction site for the wild-type and the
mutated structure. The linear correlation between both structures
was measured by the Pearson product-moment correlation
coefficient [80]. Since a transcript can hold several RBP-binding
sites we selected for each SNP the smallest correlation coefficient
per transcript. To evaluate the significance of a change in the
RNA structural ensemble we calculated the minimal correlation
coefficient for all SNPs of all 1000 random samples. Based on this
distribution we determined a correlation coefficient of 0.55 having
a probability of less than 5% for a type I error (Figure 1C). All
SNPs inducing a minimal correlation coefficient of less than 0.55
between wild-type and mutated structure were filtered.
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TofindallpossibleMREswesearchedforsitescomplementarytoa
canonical miRNA seed sequence [47] within the wild-type and
mutated39-UTRs.Theseekingforshortsequencematchesmayyield
a plethora of putative target sites with a high false positive rate. The
CLIP-seq methods have been shown to significantly reduce the
fractionoffalsepositiveMREs[14,15].Thus,weclassifiedMREsas
functionaliftheywerelocatedwithinadistanceof21 nttothecenter
ofaRBPinteractionsite[14].Toadditionallyreducetherateoffalse
positiveswerequiredatleastonemiRNAsequencereadasreported
in the accordant Clip-Seq experiment. Further, the enrichment of
MREsofeachmiRNAwithinRISC-bindingregionswascalculated.
ToidentifyMREsdisruptedbyaSNPwefiltered miRNAsofwhich
MREs were significantly overrepresented within RISC-binding
regions(LORw0,Px2v0:05).ThedeterminationofMREscreated
by SNPs was performed analogous (LORw0, Px2v0:05). We
retrieved258miRNAsthetargetingofwhichcouldbedisturbedand
324 miRNAs the formation of mRNA:miRNA hybrids of which
could be enhanced.
Functional Annotation of Genes Containing 39-UTR SNPs
We evaluated the enrichment of functional annotations of the
326 genes containing 39-UTR SNPs using DAVID [34,35] and
GSEA [81,82]. Additionally, the genes were annotated according
to their associated traits investigated in the corresponding GWAS.
To this end, all traits were mapped to official disease terms as
contained in the MeSH (Medical Subject Headings) ontology. As
disease class we used the upmost level in the hierarchy tree. Trait
enrichment analysis limited to the associated traits as contained in
the GWAS Catalog was performed using a x2 test statistic [80].
For multiple testing correction in Gene Ontology [83] term and
disease class enrichment analysis we employed the Bonferroni
correction with an overall significance level of a~0:05.
Construction of Qualitative Systems Biological Models
For retrieval of phenotype-specific microRNA expression
alterations we used PhenomiR [2] and miR2Disease [1]. The
interaction data for constructing the network were obtained by
manual text-mining and using the public databases IntAct [84],
CORUM [85] and KEGG [86–88]. Expression data was taken
from the MuTHER study [48], made accessible through the Java-
interface Genevar [89]. As in the MuTHER study the association
of expression values to an allele is given for two separated twin
cohorts, we used a combined p-value from both sets to calculate
significance. We used Fisher’s combined p-value which was shown
to be applicable to expression data [90]. The significance level was
adjusted using the rough false discovery rate [91].
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Table S1 SNPs predicted to affect 39-UTR splicing. The
first column lists the SNP rs-numbers, in the second column the
respective transcripts are given and the third column contains the
genomic locus of the SNP including strand information of the
transcripts. The fourth column shows the conservation of the SNP
in binary code, i.e. 1 means conserved, 0 means not conserved.
The fifth column gives the type of the gained splice site, the score
column contains the likelihood of NNSplice and the last column
provides the percentage of lost RBP binding sites for the accordant
transcripts.
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Table S2 SNPs predicted to affect 39-UTR secondary
structure. The first column lists the SNP rs-numbers, in the
second column the respective transcripts are given and the third
column contains the genomic locus of the SNP including strand
information of the transcripts. The fourth column shows the
conservation of the SNP in binary code, i.e. 1 means conserved, 0
means not conserved. The fifth column lists the correlation
coefficient of the wild-type structure to the mutated structure of
the respective transcripts.
(XLS)
Table S3 SNPs disrupting existing MREs. The first
column lists the SNP rs-numbers, in the second column the
respective transcripts are given and the third column contains the
genomic locus of the SNP including strand information of the
transcripts. The fourth column shows the conservation of the SNP
in binary code, i.e. 1 means conserved, 0 means not conserved.
The fifth column lists the miRNAs the MREs of which are
affected.
(XLS)
Table S4 SNPs creating new MREs. The first column lists
the SNP rs-numbers, in the second column the respective
transcripts are given and the third column contains the genomic
locus of the SNP including strand information of the transcripts.
The fourth column shows the conservation of the SNP in binary
code, i.e. 1 means conserved, 0 means not conserved. The fifth
column lists the miRNAs for which MREs are created.
(XLS)
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